UPDATE ON BIOTECH BEAR ETF LABD FOR AGGRESSIVE INVESTORS ONLY $LABD

UPDATE ON BIOTECH BEAR ETF LABD FOR AGGRESSIVE INVESTORS ONLY $LABD

This post was just published on ZYX Buy Change Alert.

Please see the Morning Capsule for Trump Cummings meeting. Trump also stated that he is going to curb high drug prices in his address before the Congress.  The market does not believe Trump and they keep on running pharmaceutical and biotech stocks on the belief that Trump will not succeed and drug prices will continue to go up.

This inverse ETF will go up if biotech and drug stocks fall.  This ETF is leveraged and can move in a wide range.  For this reason, consider reducing the recommended position size if it does not suit your risk profile and also if you are not holding significant long positions.

This is an asymmetric trade in that the potential rewards are significantly more than the commensurate risk.  On the flip side this position has more risk than most other positions in the portfolio.

LABD buy zone is $9.50 to $10.52.  First target remains $19.50 to $20.  The second target remains $26 to $30.  Stop zone is $7.60 to $8.68.  The ETF is trading at $10.20 as of this writing.

For your convenience a prior post is being republished here.

LABD is a triple leveraged inverse ETF which moves up when biotech and drug stocks go down.  The present prices of drugs in the U. S. are simply unsustainable.  Trump has said that drug companies are getting away with murder.  All it will take is another tweet from Trump or a bill introduced in the Congress by Republicans to make drug and biotech stocks go down.

Lately there has been a lot of buying in these stocks on the theory that the market has moved up and there is too much risk in stocks that have been performing well such as financials, industrials, technology and energy.  For this reason, some money managers are aggressively buying laggards including drug and biotech stocks.  Please remember that many money managers have a compulsion to buy to stay nearly 100% invested.  We do recognize that several of our subscribers who are money managers face the same compulsion.  However our subscribers who are private investors, hedge funds, or registered investment advisors do not face such a compulsion and should not consider buying laggards with poor fundamentals just for the sake of being fully invested.

This is an asymmetrical trade with potentially very high profits but lower commensurate risk relative to potential rewards,  although absolute risk is very high.

The new buy zone is $9.50 to $12.52.  Please be aware that this ETF can trade in a very wide range.  First target remains $19.50 to $20.  The second target remains $26. to $30.  Stop zone is $7.60 to $8.68.  In determining the quantity, please remember that it is triple leveraged.  The quantity used should be one-third of a normal position.  Consider not exceeding 25% of the full core position size but less if you do not want to take that much risk.

This is suitable only for super aggressive investors because of triple leverage and potential movement in a wide range.  If you are not a super aggressive investor, keep the quantity very, very small.

 

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

UPDATE ON BIOTECH BEAR ETF LABD $LABD $LABU $PPH $PJP $PFE $JNJ $MRK $BMY $BBH $IBB $XBI

This post was just published on ZYX Buy Change Alert. In our divided country there are very few things on which Republicans and ...

A SPECIAL NOTE FOR NEW SUBSCRIBERS, LONG-TERM INVESTMENTS AND/OR SHORT-TERM TRADES, AN IMPORTANT TIP $FLXN $XBI $IBB $LABU $LABD $SPY

This post was just published on ZYX Buy Change Alert.  Our subscribers have a wide range of interests. Some focus only on long-term ...

A NEW TRADE IDEA: BIOTECH COMPANY MAY HAVE A CURE FOR THE CANCER THAT KILLED APPLE’S STEVE JOBS $AAAP $AAPL $IBB $LABD $XBI $LABU

I’m constantly exposed to speculative biotechnology companies with promising treatments. But few pass our investing screens. Advanced Accelerator Applications SA AAAP,  ...

BIOTECH BEAR ETF LABD: TRUMP SAYS DRUG PRICES MUST BE REDUCED IMMEDIATELY $LABD

This post was just published on ZYX Buy Change Alert. In his speech, Trump said that drug prices must be reduced immediately.  The ...

BIOTECH BEAR ETF LABD: FUND MOVES INTO BIOTECHS AFTER LIQUIDATING PRECIOUS METAL STOCKS $LABD $XBI $IBB $GDX $GDXJ $DUST $NUGT

This post was just published on ZYX Buy Change Alert. Please see the Morning Capsule for apparently a fund moving money from liquidating ...

INITIATE OR ADD TO BIOTECH BEAR ETF LABD $LABD

This post was just published on ZYX Buy Change Alert. (Certain portions of this post are copied from an earlier post but zones ...

BIOTECH BEAR ETF LABD ON THE MOVE ON TRUMP SPECULATION, INITIATE OR ADD $LABD

This post was just published on ZYX Buy Change Alert. LABD is a triple leveraged inverse biotech ETF.  In plain English, this is ...

TRUMP SAYS INSURANCE FOR ALL IN OBAMACARE REPLACEMENT, BENEFIT FOR FIVE POSITIONS IN OUR PORTFOLIO $LABD $CNC $CYH $MOH $THC

This post was just published on ZYX Buy Change Alert.  Over the weekend, Trump has stated that he wants insurance for all in ...

WHAT PHARMA INVESTORS OUGHT TO DO AFTER DONALD TRUMP FIRES A SALVO $LABD $PFE $JNJ $MRK $BMY $LLY $PJP $IHE $PPH $IBB $XHI $BBH $BIS

Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. ...

INITIATE OR ADD TO BIOTECH BEAR ETF LABD BASED ON TRUMP COMMENT $LABD $IBB $XBI $PJP $PPH $XPH $IHE $BMY $MRK

This post was published on ZYX Buy Change Alert. Initiate or add in the zone of $13.50 to $14.52. Suitable only for aggressive investors ...

Follow

Get every new post delivered to your Inbox

Join other followers